Tirzepatide staying a dual GLP-1 and GIP agonist, it is advised which the GIP element of twin agonism may very well be chargeable for the additional gain, given the potential benefit of GIP receptor agonism on peripheral insulin sensitization. As a result, tirzepatide was more practical than dulaglutide in minimizing fasting dietary TAG [6,seven].